NASDAQ · MLABTechnologyIndustrial Instruments

Mesa Laboratories Inc (MLAB)

$125.48+2.88%
Close Nov 3, 2026 · split-adjusted
Nov 2, 2026$121.97▲ 65.83% in range
Nov 3, 2025Low $70.60 · High $142.23Nov 2, 2026
What changed · written from our data
As of Nov 3, 2026

Mesa Laboratories closed at $125.48 on Nov 3, up 2.88%, 11.8% below its 52-week closing high. Volume of 91.5K shares was 0.98× its 20-day average (close to normal).

Split-adjusted performance: -11.8% over one month, +20.8% over six months, +74.5% over one year.

In the quarter ended Jun 30, 2026, revenue was $60.14M, up 1.0% from a year earlier, with a net margin of 4.7%.

Short interest was 390.6K shares at the Oct 15 settlement, down 12.6% from the prior report (7.7% of float, 3.8 days to cover).

Market cap$702.2M5.6M shares
Revenue · quarter$60.1M+1.0% YoY
Diluted EPS$0.49−42.4% YoY
P/E · TTM146.3×P/S 2.8×
Net margin4.7%Gross 64.9%
Dividend yield0.51%$0.16 last paid
52-week range70.60 – 142.23−11.8% from high
Volume91.5K0.98× 20-day avg
Volatility · 60d48.5%Annualised
Short % of float7.7%3.8 days to cover
Net cash-$112.2MCash $30.7M
Next earnings—Not scheduled
Split-adjusted performance
1W −2.9%1M −11.8%3M +22.3%6M +20.8%YTD +59.8%1Y +74.5%3Y +30.0%5Y −59.1%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Industrial Instruments

Percentile among 15 companies (100 = best)

6-month momentum64
Revenue growth8
Net margin29
Value (low P/E)0
Size36

Industry medians: 6-month return +6.0%, revenue growth +11.7%, net margin 11.4%, P/E 36.2×.

Short interest

Details →
Shares short390.6K−12.6% vs prior
Days to cover3.8Settled Oct 15
% of float7.7%
Short vol. 10d62.2%of daily volume

Closest peers by size in Industrial Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
MLABMesa Laboratories$125.48+2.88%+20.8%+1.0%4.7%146.3$702.2M
SENSSenseonics Holdings$8.86−1.34%+77.2%+117.8%−253.4%—$468.5MCompare
HURCHurco Cos$22.04+0.69%+28.9%+3.2%4.7%—$142.7MCompare
STSensata Technologies Holding$41.64+0.99%−2.8%+7.7%11.4%16.5$6.06BCompare
RALRalliant$71.31+7.54%+53.5%—10.1%—$7.89BCompare
CGNXCognex$58.11+3.01%−1.2%+16.9%25.0%55.9$9.78BCompare
MKSIMKS$205.18+4.40%−28.7%+28.3%14.0%31.5$13.87BCompare
SYPRSypris Solutions$1.34+3.88%−61.5%−3.5%−10.3%—$30.9MCompare
FTVFortive$66.81−0.04%+10.1%+7.8%15.6%30.5$19.89BCompare

Quick answers

What does Mesa Laboratories do?
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes.
What is MLAB's market cap?
$702.17M, based on the Nov 3 close of $125.48.
What is MLAB's P/E ratio?
146.3× trailing-twelve-month earnings of $4.80M.
Does Mesa Laboratories pay a dividend?
Yes. The latest regular dividend was $0.16 per share (ex-date Aug 31), an annualised yield of 0.51%.
How much of MLAB is sold short?
390.6K shares, 7.7% of float, as of Oct 15, 2026.
What sector is MLAB in?
Technology, in the Industrial Instruments industry.

About Mesa Laboratories

Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.

HQ: Lakewood, CO717 employeesListed Feb 29, 1984mesalabs.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology